Seiteninterne Suche

Erich Malter Erlangen

Honorary doctorate for Norbert Pelc

Prof. Norbert J. Pelc, ScD, Stanford University, California, was conferred the degree Doktor der Medizin honoris causa (Dr. med. h.c.).


New method to determine the risk of skin cancer relapse

How likely do patients develop again cancer after a tumor has been surgically removed? This is the central question of the new research project „MelEVIR – Melanoma, Extracellular Vesicles, and Immune Response“.

(c) Rainer Windhorst, 2016

Jakob Herz Prize 2016

Jakob Herz Prize 2016: Solemn prize giving ceremony and successful birthday party

Photo: Matthias Jung

DFG supports new research training group

The German Research Foundation (DFG) supports a new research training group (GRK) for the coming 4.5 years with a focus on interdisciplinarity and neurosciences: "Neurodevelopment and CNS Vulnerability" (Speaker: Prof. Dr. D.C. Lie, Institute of Biochemistry).

Photo: S. Krikava

Welcome the Faculty of Medicine at Friedrich-Alexander-Universität Erlangen-Nürnberg! Discover the excellent research conditions and the high quality of life in the region!

The Department of Medicine 4 is a member of a worldwide consortium that has the aim of improving treatment of chronic kidney disease.

Researchers at the Department of Neurology demonstrated the significant influence of new signal paths of the renin-angiotensin system (RAS).

FAU has demonstrated its strength in research once again: the University is conducting a new research project together with Siemens Healthcare GmbH, Universitätsklinikum Erlangen and other European partners in which researchers will develop an innovative hybrid device that combines different medical imaging technologies and will help stroke patients in particular to receive quicker diagnosis and treatment.

Dendritic cells represent an important component of the immune system: they recognize and engulf invaders which subsequently triggers a pathogen-specific immune response. Scientists of the Department of Dermatology and the LIMES Institute of the University of Bonn gained substantial knowledge of human dendritic cells which might contribute to the development of immune therapies in the future.